Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

stage II non-small cell lung cancer

Known as: Stage II Non-Small Cell Carcinoma of the Lung, stage II nonsmall cell lung cancer, lung cancer, non-oat cell, stage II 
Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor… Expand
National Institutes of Health

Related topics

Related topics

15 relations
ChestEGFR Gene MutationEGFR geneEpithelial Cells
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial
BackgroundImmunotherapies targeting the PD1/PD-L1 pathway have had a large impact on the treatment of advanced NSCLC. Concerning… Expand
  • table 1
  • figure 1
Is this relevant?
2017
2017
Poster ViewingSBRT for Stage II NSCLC: An Analysis of the National Cancer Database
 
Is this relevant?
2017
2017
P1.05-069 Stage II NSCLC Treated with Non-Surgical Approaches: A Multi-Institution Report of Outcomes: Topic: Miscellaneous
 
Is this relevant?
2014
2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in…
OBJECTIVES Neoadjuvant therapy with a platinum based doublet is an option in NSCLC patients with upfront resectable disease… Expand
  • figure 1
  • table 1
  • table 3
  • figure 2
  • table 2
Is this relevant?
2014
2014
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
INTRODUCTION This study examined rates of tumor progression in treatment-naive patients with non-small-cell lung cancer (NSCLC… Expand
Is this relevant?
2012
2012
Lung cancer in Berlin - Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008
Backgroud: The Tumorzentrum Berlin (TZB) amalgamates the clinical data of lung cancer pts. in order to improve pt. care by means… Expand
Is this relevant?
2012
2012
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.
Lung cancer is the no.1 cancer killer in both men and women. Non-small lung cancer (NSCLC) comprises about 80% of all lung… Expand
Is this relevant?
Review
2010
Review
2010
Adjuvant therapy in early-stage non-small cell lung cancer.
  • Monika Serke
  • Frontiers of radiation therapy and oncology
  • 2010
    • Corpus ID: 23633876
Evidence clearly supports adjuvant chemotherapy following resection in patients with stage II or III non-small cell lung cancer… Expand
Is this relevant?
2007
2007
The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
OBJECTIVE To investigate the role of growth/adhesion-regulatory lectins in the prognosis of the stage II non-small cell lung… Expand
  • table 1
  • table 2
  • figure 1
  • table 5
  • figure 2
Is this relevant?
2007
2007
Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study.
BACKGROUND The aim of this study was to determine the overall survival, progression-free survival, and toxicity associated with… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE